Fundraising September 15, 2024 – October 1, 2024 About fundraising

High Response Rate for Treatment With Gemtuzumab Ozogamicin...

High Response Rate for Treatment With Gemtuzumab Ozogamicin and Cytarabine in Elderly Patients With Acute Myeloid Leukemia and Favorable and Intermediate-I Cytogenetic Risk

Sigal Tavor, Einam Rahamim, Nadav Sarid, Uri Rozovski, Lili Gibstein, Freddy Aviv, Ilya Kirsner, Elizabeth Naparstek
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Year:
2012
Language:
english
DOI:
10.1016/j.clml.2012.05.007
File:
PDF, 313 KB
english, 2012
Conversion to is in progress
Conversion to is failed